Latest Posts

21 Jun 2018

MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC

      By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.

0
14 Jun 2018

VEIN SPECIALISTS PODCAST WITH VTN’S OWN GARY PITTMAN

Gary Pittman from Vein Therapy News joins Vein Specialists today to discuss his background and experience with the vein industry. Vein Therapy News is teaming with the latest news on products, services, and breakthroughs in the vein treatment industry. We discuss technology and how it is changing the face of

0
13 Jun 2018

CASE STUDY: MANAGING PERSISTENT SWELLING AFTER ENDOVENOUS ABLATION

  By Tim Crawlield I have practiced phleboloby for six years and I learned early in my career that patients with swelling in the lower extremities — swelling that cannot be contained by elastic graduated compression stockings — do not benefit from endovenous ablations. My general rule of thumb is

0
13 Jun 2018

2018 RESEARCH SUMMIT: WORK BEGINS TO ANALYZE DATA IN RAPIDLY EXPANDING ACP PRO VENOUS REGISTRY

By Vanessa Salvia Contributing Editor Anticipation was high for many members of the phlebology community going into an April 21 closed-door research summit held alongside the International Vein Congress in Miami, convened to discuss how to make the most of the American College of Phlebology’s Patient Recorded Outcome Venous Registry,

0
07 Jun 2018

OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0
SHARE

Home